Nasal Septal HematomaMANAGEMENT

ENT AND MAXILLOFACIAL PRESENTATIONS · 12 SECTIONS

⚲

456 items

☷ Legend

⚲

Cardiovascular Presentations71▾

Respiratory Presentations52▾

Neurological Presentations83▾

Gastrointestinal Presentations74▾

Genitourinary and Reproductive Presentations48▾

Infectious Disease Presentations148▾

Trauma Presentations89▾

Toxicologic Presentations80▾

Psychiatric Presentations26▾

Musculoskeletal and Rheumatologic Presentations96▾

Dermatology Presentations23▾

Environmental and Exposure Presentations27▾

Hematologic and Oncologic Presentations36▾

Pediatric-Specific Presentations19▾

Endocrine and Metabolic Presentations45▾

ENT and Maxillofacial Presentations27▾

Acute laryngitis Acute pharyngitis Auricular hematoma Bezold's Abscess Cerumen impaction Dry socket Ear foreign body Epistaxis (anterior)Epistaxis (Posterior)Labyrinthitis Ludwig's Angina Malignant Otitis Externa Marcus Gunn Pupil Mastoiditis Meniere's Disease Nasal Bone Fracture Nasal foreign body Nasal Septal Hematoma Otitis externa Otitis Media Post-tonsillectomy hemorrhage Sialolithiasis and sialadenitis Sinusitis Sudden Sensorineural Hearing Loss TMJ dislocation Tympanic membrane perforation Vestibular Neuronitis

Ophthalmologic Presentations19▾

Obstetric Presentations23▾

Systemic and Miscellaneous Presentations17▾

01Approach to the Critical Patient/attcp35

Immediate recognition

›ENT emergency requiring urgent action

›Nasal septal hematoma is a rare but true ENT emergency

›Avascular septal cartilage depends entirely on mucoperichondrium for blood supply

›Hematoma separating cartilage from perichondrium causes ischemia within hours

›Cartilage necrosis and abscess can develop within days of untreated hematoma

›Brain abscess reported as fatal complication of infected septal hematoma

›Time-critical triggers

›Urgent drainage required within 24-48 hours of diagnosis

›Delayed diagnosis is common — 82% of pediatric cases initially missed in ED

›Median time to diagnosis 7 days with average 2.2 ED visits before recognition

›Missed in 46% of cases across multiple clinical settings

Alarm features requiring immediate escalation

›Intracranial complication concern

›Headache, periorbital swelling, or visual changes

›Altered mental status or focal neurologic signs

›Meningismus or photophobia

›If intracranial spread suspected, emergent CT and neurosurgery consult

›Septal abscess features

›Fever with purulent nasal discharge

›Mean symptom duration for abscess 7.6 days vs 4.1 days for hematoma

›If abscess confirmed, urgent ENT consult and IV antibiotics

›Saddle nose deformity on presentation

›Cartilage necrosis has already occurred

›ENT consult for reconstructive planning

Initial stabilization

›Stabilization priorities

›Concurrent epistaxis control if present

02History/hx44

Mechanism and onset

›Trauma history

›Direct nasal trauma present in approximately 85% of cases

›Mechanisms: assault, sports injury, fall, motor vehicle accident

›Nasal or sinus surgery (septoplasty, rhinoplasty, epistaxis cauterization)

›Non-traumatic presentation warrants consideration of sinonasal neoplasm

›Timing of symptoms

›Acute or delayed onset up to 48-72 hours post-injury

›Progressive bilateral nasal obstruction after trauma

›Worsening obstruction despite decongestants

Presenting symptoms

›Core symptoms

›Bilateral nasal congestion and obstruction (bilateral is hallmark)

›Nasal pain and pressure sensation

›Rhinorrhea (clear vs purulent)

›Epistaxis at time of trauma

›Symptoms suggesting progression to abscess

›New-onset fever or chills

›Purulent nasal discharge

›Worsening pain or facial swelling despite initial treatment

›Malaise and systemic illness

Alarm symptoms

›Neurologic red flags

›Headache

›Visual changes or periorbital swelling

›Altered mental status or confusion

›Facial numbness (intracranial extension concern)

›Constitutional

03Physical Exam/exam31

Vital signs

›Vital sign assessment

›Fever suggests abscess or systemic infection

›Tachycardia with fever raises intracranial complication concern

›Hemodynamic stability assessment for concurrent trauma

Anterior rhinoscopy

›Pathognomonic findings

›Bilateral boggy, bluish-red, fluctuant swelling of the nasal septum

›Narrows or obliterates both nasal passages

›Painful septal swelling with nasal obstruction present in 100% of NSH patients

›Palpation technique

›Cotton-tipped applicator gently pressed on septal swelling

›Fluctuance and compressibility confirm hematoma

›Firm non-compressible septum suggests deviated septum not hematoma

›This is the single most important bedside maneuver

External nasal exam

›Structural assessment

›Swelling and ecchymosis over nasal dorsum

›Nasal deformity suggesting fracture

›Tenderness and crepitus on palpation (concurrent nasal fracture)

›Saddle nose deformity (indicates cartilage necrosis)

›Skin and soft tissue

›Erythema and warmth suggesting cellulitis or abscess

›Periorbital edema (intracranial extension concern)

›Purulent nasal drainage

Neurologic exam

›Neurologic assessment

›Cranial nerve II, III, IV, VI evaluation for intracranial involvement

04Differential Diagnosis/ddx32

Life-threatening mimics

›Nasal septal abscess

›ICD-10: J34.0 — abscess of nasal septum

›Most dangerous progression from untreated hematoma

›Distinguished by fever, purulent discharge, fluctuance, longer symptom duration

›S. aureus isolated in approximately 70% of abscess cases

›Intracranial complication of septal abscess

›Meningitis, cavernous sinus thrombosis, brain abscess, subdural empyema

›Suspect with headache, visual changes, altered mental status

Structural causes of nasal obstruction

›Deviated nasal septum

›ICD-10: J34.2

›Chronic, non-tender, firm on palpation (not boggy or fluctuant)

›No antecedent trauma or acute onset

›Nasal polyps

›ICD-10: J33.0

›Pale, glistening, non-tender, insensate on palpation

›Chronic history, bilateral in most cases

›Inferior turbinate hypertrophy

›Common misdiagnosis in NSH

›Located on lateral nasal wall not septal

›Responds to decongestants

Other nasal pathology

›Nasal bone fracture without hematoma

›ICD-10: S02.2

›External deformity, crepitus, but no septal swelling

›May coexist with NSH

›Nasal foreign body (pediatric)

05Laboratory Tests/lt22

Routine labs

›Uncomplicated hematoma

›Routine laboratory studies generally not required

›NSH is a clinical diagnosis made by anterior rhinoscopy

›Reserve labs for suspected infection or comorbidities

Labs for suspected abscess or infection

›Microbiologic testing

›Culture and sensitivity of aspirated material

›S. aureus isolated in approximately 70% of cases including MRSA strains

›In children also consider H. influenzae and S. pneumoniae

›Guides antibiotic de-escalation after drainage

›Hematologic testing

›Complete blood count with differential

›Leukocytosis suggests infection or abscess

›Thrombocytopenia if bleeding disorder suspected

›Metabolic testing

›Blood glucose and HbA1c

›Screen for undiagnosed diabetes particularly in spontaneous abscess

›Diabetes present in 47% of adult abscess cases

›Basic metabolic panel if systemic infection or sepsis concern

Coagulation studies

›Coagulopathy assessment

›PT/INR and aPTT if bleeding disorder suspected or patient on anticoagulants

›Coagulopathy not statistically significantly associated with NSH incidence in one large series

›Still obtain if clinical suspicion or anticoagulant use

06Diagnostic Tests/dt40

Scoring Systems

›No validated scoring systems for NSH

›No published decision rules or validated risk stratification tools exist for NSH

›Diagnosis is clinical based on history, mechanism, and anterior rhinoscopy

›Clinical diagnosis sufficient in straightforward presentations

›Needle aspiration can confirm diagnosis: blood confirms hematoma, pus confirms abscess

MRI

›MRI indications and performance

›MRI head with contrast superior for intracranial complications

›Diagnostic accuracy 97% vs 87% for CT in detecting intracranial spread

›Preferred for meningitis, cavernous sinus thrombosis, brain abscess detection

›Subdural empyema detection

›MRI protocol

›T1 post-contrast and FLAIR sequences for intracranial infection

›DWI for abscess characterization

›Limitations

›Less available after hours

›Not indicated for routine uncomplicated hematoma

›Longer acquisition time versus CT in unstable patients

›CT indications

›Not required for straightforward clinical diagnosis

›NSH is a clinical diagnosis by anterior rhinoscopy

›Reserve for specific indications

›CT face and sinuses with contrast: specific indications

›Concern for concurrent facial fractures

›Suspected intracranial or orbital complications

›Posterior septal abscess not visible on anterior rhinoscopy

07Disposition/dispo27

Discharge criteria

›Uncomplicated hematoma suitable for discharge

›Small uncomplicated hematoma drained in ED with adequate decompression

›No fever or signs of systemic infection

›No signs of intracranial complications

›Reliable follow-up achievable

›ENT follow-up arranged within 24-48 hours for packing removal and re-examination

›Adult or adolescent with reliable caregiver if pediatric

Admission indications

›Admit for the following

›Septal abscess confirmed or suspected

›Requires IV antibiotics

›Risk of rapid progression to intracranial complications

›Pediatric patient requiring OR drainage under general anesthesia

›Signs of systemic infection or sepsis

›Intracranial complications on imaging

›Significant comorbidities: uncontrolled diabetes, immunosuppression

›Inadequate home circumstances or inability to ensure follow-up

Transfer criteria

›Transfer indications

›Intracranial complications requiring neurosurgical intervention

›Facility without ENT or OR capability for pediatric drainage under general anesthesia

›Septal reconstruction required after cartilage destruction

Follow-up requirements

›Mandatory follow-up

›ENT re-evaluation within 24-48 hours post-drainage

›Packing removal

›Assessment for re-collection (re-collection rate after I&D approximately 3.6%)

08Treatment/t63

Initial management

›Concurrent injury management

›Epistaxis control

›Anterior packing or vasoconstrictive agents

›Oxymetazoline topical for mucosal decongestion during examination

›Facial fracture assessment and management

›Analgesia

›Oral analgesics appropriate for pain severity

›Avoid NSAIDs in acute period if bleeding concern

Incision and drainage

›Definitive treatment: I&D

›Urgent drainage required within 24-48 hours of diagnosis

›Timing principle: earlier drainage prevents cartilage necrosis

›Adults: may be performed under local anesthesia in ED

›Pediatric patients: most require general anesthesia in OR

›Anesthesia for ED drainage in adults

›Topical anesthesia: 4% lidocaine or cocaine solution applied intranasally

›Local infiltration: lidocaine 1-2% with epinephrine 1:100,000

›Epinephrine for vasoconstriction and hemostasis

›Inject along nasal floor and columellar base

›Drainage technique

›Hemitransfixion incision through mucoperichondrium at inferior-anterior septum

›Incision along caudal septum parallel to floor of nose

›Evacuate clot with suction and gentle curettage

›Irrigate cavity with saline

›Needle aspiration alternative for very early non-clotted hematomas

›18-gauge needle aspiration may suffice if blood is liquid

›Higher re-accumulation rate than formal I&D

09Special Populations/sp63

Pregnancy

›Pregnancy considerations

›Mechanism and presentation unchanged in pregnancy

›Nasal trauma from same mechanisms as general population

›Pregnancy-related nasal mucosal engorgement may alter examination findings

›Imaging approach in pregnancy

›Anterior rhinoscopy sufficient for diagnosis — no radiation required

›CT face with shielding only when facial fracture assessment cannot be deferred

›MRI without gadolinium preferred if intracranial complication suspected

›Gadolinium contrast avoided in first trimester unless critical indication

›Antibiotic selection in pregnancy

›Amoxicillin-clavulanate: Category B, generally considered safe

›First-generation cephalosporins: safe in all trimesters

›Avoid tetracyclines (dental staining and bone effects in fetus)

›Vancomycin: use with caution, monitor for ototoxicity and nephrotoxicity

›Procedural considerations

›Local anesthesia with lidocaine and epinephrine generally safe

›Obstetric team notification for OR procedures in pregnancy

›Fetal monitoring appropriate for viable gestation

Geriatric

›Older adult considerations

›Risk factor profile

›Falls as common mechanism (in addition to trauma from assault/sports)

›Anticoagulant and antiplatelet use more prevalent

›Higher prevalence of diabetes mellitus and immunosuppression

›Anticoagulation management

›Hold anticoagulants peri-procedurally in consultation with prescribing team

›Reversal agents if urgent drainage required on therapeutic anticoagulation

›Warfarin: vitamin K and 4-factor PCC if emergent reversal needed

›Antibiotic dosing adjustments

›Renal dosing of amoxicillin-clavulanate if eGFR less than 30 mL/min

›Vancomycin AUC-guided dosing with renal function monitoring

›Higher risk for C. difficile colitis with broad-spectrum antibiotics

›Abscess risk

›Diabetes and immunosuppression increase progression to abscess

›Lower threshold for admission and IV antibiotics

›Long-term complications

›61.7% of patients experienced minor or major sequelae over mean 8.7 year follow-up

›Saddle nose deformity most common major complication

Pediatrics

›Pediatric specific features

›Epidemiologic differences

›Mean age approximately 7 years in pediatric studies

›Male predominance: 92% male in pediatric series

›Missed in 82% of pediatric ED cases with mean time to diagnosis of 7 days

›Cartilage considerations

›Pediatric septal cartilage is thicker and more vascular than adult

›However cartilage destruction also impairs midface growth — permanent deformity

›Urgency of drainage even greater in children for developmental reasons

›Organism coverage

›S. aureus predominant pathogen

›Also cover H. influenzae and S. pneumoniae in pediatric patients

›Procedural approach

›Most pediatric cases require general anesthesia in OR for drainage

›Cooperation limitations make adequate ED I&D difficult in young children

›Antibiotic dosing

›Amoxicillin-clavulanate: 45 mg/kg/day of amoxicillin component divided every 12 hours

›Ampicillin-sulbactam IV: 200 mg/kg/day of ampicillin component divided every 6 hours

›Cephalexin: 25-50 mg/kg/day divided every 6-12 hours, maximum 4 g/day

›Non-accidental trauma

›Inconsistent history or pattern mismatch requires child protection assessment

›Contact social work and child protective services as appropriate

›Outcomes

›50% of hematoma patients have no long-term sequelae with prompt drainage

›Only 7.7% of abscess patients have no long-term sequelae

›Long-term follow-up for saddle nose deformity and midface growth abnormalities

10Background/b51

Epidemiology

›Incidence and frequency

›Nasal septal hematoma is a rare complication of nasal trauma

›Trauma accounts for approximately 85% of cases

›Male predominance in pediatric populations: 92% male

›Pediatric mean age approximately 7 years in published series

›Adult abscess cases: diabetes present in 47%, nose-picking in 44%

›Diagnostic miss rate

›82% of pediatric cases initially missed in ED

›Median time to diagnosis 7 days with average 2.2 evaluations before diagnosis

›46% missed across multiple clinical settings

›Outcomes data

›61.7% of patients experienced minor or major long-term sequelae in a mean 8.7 year follow-up

›Saddle nose deformity is the most common major complication

›50% of hematoma patients had no sequelae vs only 7.7% of abscess patients with no sequelae

›Re-collection rate after adequate I&D approximately 3.6%

Pathophysiology

›Mechanism of hematoma formation

›Direct nasal trauma shears blood vessels in subperichondrial or submucosal space

›Blood accumulates between septal cartilage and overlying mucoperichondrium

›Mucoperichondrium stripped from cartilage surface by hematoma

›Avascular cartilage depends entirely on overlying mucoperichondrium for nutrient supply

›Progression to cartilage necrosis

›Cartilage ischemia begins immediately upon separation from perichondrium

›Proteolytic enzymes from inflammatory cells further degrade cartilage

›Necrosis can occur within days of untreated hematoma

›Results in saddle nose deformity as cartilage collapses

›Progression to abscess

11Patient Discharge Instructions/pdi32

copy discharge instructions

›Diagnosis and procedure explanation

›You have been treated for a nasal septal hematoma — a collection of blood between the cartilage and lining of the dividing wall inside your nose

›A small incision was made to drain this blood and prevent serious complications

›Nasal packing or a small drain was placed and must not be removed at home

›Wound and packing care

›Do not remove nasal packing or drain — this is removed at your follow-up appointment

›Breathe through your mouth until packing is removed

›Gentle saline nasal spray may be used to keep nasal passages moist around packing

›Keep head elevated — sleep with head of bed elevated on pillows

›No nose blowing for at least one week after the procedure

›No heavy lifting or straining for one week

›Medications

›Take prescribed antibiotics for the full course — do not stop early even if feeling better

›Pain relief: acetaminophen as directed for pain; avoid NSAIDs unless prescribed

›Do not take blood thinning medications unless directed by your physician

›Diet and activity

›Soft diet is comfortable while nasal packing is in place

›Avoid hot liquids and foods in the first 48-72 hours to reduce re-bleeding risk

›Avoid contact sports or any nasal trauma until cleared by your ENT specialist

›Follow-up appointment

›Mandatory ENT follow-up within 24-48 hours — this is critical

›Packing or drain will be removed and the nose re-examined for re-accumulation

›Additional follow-up will be arranged at that appointment

›Return to emergency department immediately for

›Worsening nasal obstruction or swelling

›New-onset fever or chills

›Purulent (green or yellow) nasal discharge

12References/r16

Guidelines and key sources

›Primary clinical evidence

›Guchlerner L et al. Nasal Septal Hematoma Is a Rare and Self-Recognizable Complication of Nasal Bone Fracture. American Journal of Otolaryngology 2025. PMID 41135290

›Ali HM et al. Nasal Septal Hematoma in Children: Time to Diagnosis and Resulting Complications. International Journal of Pediatric Otorhinolaryngology 2021. PMID 33930759

›Kass JI, Ferguson BJ. Treatment of Hematoma of the Nasal Septum. New England Journal of Medicine 2015

›Alshaikh N, Lo S. Nasal Septal Abscess in Children: From Diagnosis to Management and Prevention. International Journal of Pediatric Otorhinolaryngology 2011. PMID 21492944

›Marston AP, O'Brien EK, Hamilton GS. Nasal Injuries in Sports. Clinics in Sports Medicine 2017. PMID 28314421

›Sayin I et al. Nasal Septal Hematoma and Abscess in Children: An Uncommon Otorhinolaryngology Emergency Revisited. Journal of Craniofacial Surgery 2021. PMID 33705048

›Shaari AL et al. Nasal Septal Abscesses: A Systematic Review. Journal of Craniofacial Surgery 2025. PMID 39750551

›Jackson R, Jia W, Edafe O. Evaluation of the Management of Nasal Septal Haematoma and Abscess: A Systematic Review. Journal of Laryngology and Otology 2025. PMID 39434415

Imaging guidance

›Radiology society guidelines

›Expert Panel on Neurological Imaging. ACR Appropriateness Criteria Sinonasal Disease: 2021 Update. Journal of the American College of Radiology 2022

›Berlucchi M et al. Spontaneous Abscess of the Posterior Nasal Septum. Annals of Otology Rhinology and Laryngology 2021. PMID 33423503

›MRI head with contrast reported 97% diagnostic accuracy vs 87% for CT for intracranial complications of septal abscess

ENT epistaxis guideline

›AAO-HNS epistaxis guideline

›Tunkel DE et al. Clinical Practice Guideline: Nosebleed (Epistaxis). Otolaryngology Head and Neck Surgery 2020

›Provides guidance on concurrent epistaxis management in nasal trauma patients

Learn More: Nasal Septal Hematoma→

Comprehensive Clinical Review

Structured, evidence-informed, long-form analysis for deeper understanding.

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed August 18, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.